Nyvepria and Yellow skin - a phase IV clinical study of FDA data
We study 5,302 people who take Nyvepria or have Yellow skin. No report of Yellow skin is found in people who take Nyvepria.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Nyvepria?
Nyvepria has active ingredients of pegfilgrastim-apgf. eHealthMe is studying from 12 Nyvepria users for its effectiveness, alternative drugs and more.
What is Yellow Skin?
Yellow skin is found to be associated with 1,425 drugs and 1,029 conditions by eHealthMe.
Do you take Nyvepria and have Yellow skin?Check whether Yellow skin is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Yellow skin and when was it recovered:
Expand to all the drugs that have ingredients of pegfilgrastim-apgf:
Alternative drugs to, pros and cons of Nyvepria:
- Nyvepria (12 reports)
Yellow skin treatments and more:
- Yellow skin (5,290 reports)
COVID vaccines that are related to Yellow skin:
- Yellow skin in Moderna COVID Vaccine
- Yellow skin in Pfizer BioNTech Covid Vaccine
- Yellow skin in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Yellow skin:
All the conditions that are associated with Yellow skin:
How the study uses the data?
The study uses data from the FDA. It is based on pegfilgrastim-apgf (the active ingredients of Nyvepria) and Nyvepria (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Celexa and Anion Gap Increased - 5 seconds ago
- Darvocet-N 50 and Faecal Incontinence - 6 seconds ago
- Furosemide and Paresis - 8 seconds ago
- Tramadol and Ifex drug interaction - 10 seconds ago
- Ipratropium Bromide and Itraconazole drug interaction - 11 seconds ago
- Ampyra and Panic Reaction Aggravated - 13 seconds ago
- Hypoglycaemia Aggravated and Retinopathy Of Prematurity - 15 seconds ago
- Potassium Aspartate and Neutrophil Count Decreased - 18 seconds ago
- Lunesta and Neurological Symptom - 18 seconds ago
- Pregabalin and Premature Delivery - 19 seconds ago